全文获取类型
收费全文 | 317篇 |
免费 | 25篇 |
出版年
2023年 | 1篇 |
2022年 | 10篇 |
2021年 | 16篇 |
2020年 | 14篇 |
2019年 | 28篇 |
2018年 | 21篇 |
2017年 | 16篇 |
2016年 | 19篇 |
2015年 | 14篇 |
2014年 | 25篇 |
2013年 | 41篇 |
2012年 | 27篇 |
2011年 | 25篇 |
2010年 | 11篇 |
2009年 | 9篇 |
2008年 | 18篇 |
2007年 | 12篇 |
2006年 | 7篇 |
2005年 | 3篇 |
2004年 | 3篇 |
2003年 | 4篇 |
2002年 | 6篇 |
2001年 | 2篇 |
2000年 | 2篇 |
1999年 | 3篇 |
1997年 | 1篇 |
1995年 | 1篇 |
1980年 | 2篇 |
1979年 | 1篇 |
排序方式: 共有342条查询结果,搜索用时 218 毫秒
11.
Soudeh Ghafouri-Fard Mir Davood Omrani Mohammad Taheri 《Journal of cellular physiology》2020,235(2):818-835
Recent studies have verified the contribution of several long noncoding RNAs (lncRNAs) in the carcinogenesis. Among the highly acknowledged lncRNAs is the human homolog of the plasmacytoma variant translocation gene, which is called PVT1. PVT1 resides near Myc oncogene and regulates the oncogenic process through modulation of several signaling pathways, such as TGF-β, Wnt/ β-catenin, PI3K/AKT, and mTOR pathways. This lncRNA has a circular form as well. Expression analyses and functional studies have appraised the oncogenic roles of PVT1 and circPVT1. Experiments in several cancer cell lines have shown that PVT1 silencing suppresses cancer cell proliferation, whereas its overexpression has the opposite effect. Its silencing has led to the accumulation of cells in the G0/G1 phase and diminished the number of cells in the S phase. Moreover, genome-wide association studies have signified the role of single nucleotide polymorphisms of this lncRNA in conferring risk of lymphoma in different populations. In the current study, we have summarized recent data about the role of PVT1 and circPVT1 in the carcinogenesis process. 相似文献
12.
13.
14.
15.
16.
17.
18.
The Protein Journal - Enterokinase enzyme is widely used in production of recombinant proteins. This enzyme is isolated from the intestine and recognizes a specific cleavage site... 相似文献
19.
20.
Omid Reza Tamtaji Moein Mobini Russel J. Reiter Abolfazl Azami Mohammad Saeed Gholami Zatollah Asemi 《Journal of cellular physiology》2019,234(6):7788-7795
Toll-like receptors (TLRs) are crucial activators of inflammatory responses, they are considered immune receptors. TLRs are of fundamental importance in the pathophysiology of disorders related to inflammation including neurodegenerative diseases and cancer. Melatonin is a beneficial agent in the treatment of inflammatory and immune disorders. Melatonin is potent anti-inflammatory hormone that regulates various molecular pathways. Withal, limited studies have evaluated the inhibitory role of melatonin on TLRs. This review summarizes the current knowledge related to the effects of melatonin on TLRs in some common inflammatory and immunity disorders. 相似文献